John Thievon saves the Dey for Mylan

Mylan has appointed John Thievon president of Dey Pharma, its fully integrated specialty pharmaceutical business. Mr Thievon most recently served as president and CEO of MiddleBrook Pharmaceuticals, helping to build the business from an 18-person start-up to a 450-person organisation whose assets were acquired by Victory Pharma.